Press Releases 2006

Date Announcements Attachment
Dec 18, 2006 Patient Recruitment for Phase 2B HIV Trial completed PDF file - 70.66 KB
Dec 8, 2006 Avexa raises $9.75 million in 2006 Share Purchase Plan PDF file - 55.44 KB
Dec 6, 2006 Avexa's Antibacterial Program shows systemic activity PDF file - 74.87 KB
Dec 4, 2006 Avexa and Target Drug sign Binding Term Sheet for CCR5 HIV Program PDF file - 60.84 KB
Nov 27, 2006 Avexa announces extension of Share Purchase Plan PDF file - 41.79 KB
Nov 22, 2006 Avexa gets all clear from Phase 1 Cardiac Safety Trial PDF file - 64.51 KB
Nov 9, 2006 Avexa Antibiotic is Active in Animal Proof of Concept Study PDF file - 65.08 KB
Oct 27, 2006 Avexa Announces 2006 Share Purchase Plan PDF file - 159.83 KB
Oct 24, 2006 AGM Chairman's Address 2006 PDF file - 61.03 KB
Oct 24, 2006 AGM CEO presentation 2006 PDF file - 104.33 KB
Sep 25, 2006 Notice of Meeting 2006 PDF file - 29.37 KB
Sep 14, 2006 Update on Apricitabine's Clinical Development PDF file - 65.92 KB
Aug 8, 2006 Avexa's strong financial position provides foundation for promising year ahead PDF file - 25.51 KB
Jul 24, 2006 Update on Apricitabine's Development PDF file - 26.58 KB
May 10, 2006 Avexa's Capital Raising Oversubscribed PDF file - 49.22 KB
Apr 3, 2006 Avexa secures US placement and announces rights issue in a $14.4 million capital raising PDF file - 45.63 KB
Apr 3, 2006 Appendix 3B New Issue Announcement 3 April 2006 PDF file - 79.03 KB
Apr 3, 2006 Prospectus for Non-Renounceable Rights Issue 3 April 2006 PDF file - 144.25 KB
Mar 15, 2006 Avexa ramps up Phase 111 preparations for AVX754 PDF file - 20.38 KB
Feb 13, 2006 Avexa announces Half Yearly Results PDF file - 60.15 KB
Feb 8, 2006 Avexa signs exclusive licence agreement with MNLpharma PDF file - 58.15 KB
Jan 25, 2006 Appendix 4C Quarterly Report PDF file - 62.12 KB
Nov 30, 1999 Annual Report 2006 PDF file - 347.12 KB
Note: Our attachments use Adobe PDF which means you may have to use an Acrobat Reader. You can download Acrobat from the Adobe Website.